CCM
CVS icon

Catawba Capital Management’s CVS Health CVS Stock Holding History

Catawba Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$7.28M Buy
113,108
+652
+0.6% +$43K 1.71% 8
2018
Q1 		$7M Sell
112,456
-2,262
-2% -$162K 1.68% 12
2017
Q4 		$8.32M Sell
114,718
-4,545
-4% -$330K 1.88% 6
2017
Q3 		$9.7M Sell
119,263
-1,972
-2% -$156K 2.19% 3
2017
Q2 		$9.76M Buy
121,235
+2,302
+2% +$182K 2.22% 3
2017
Q1 		$9.34M Sell
118,933
-240
-0.2% -$19.2K 2.04% 5
2016
Q4 		$9.4M Sell
119,173
-4,972
-4% -$402K 2.2% 3
2016
Q3 		$11M Sell
124,145
-3,003
-2% -$283K 2.62% 2
2016
Q2 		$12.2M Sell
127,148
-812
-0.6% -$80.9K 2.96% 2
2016
Q1 		$13.3M Buy
127,960
+2,849
+2% +$277K 3.38% 2
2015
Q4 		$12.2M Sell
125,111
-1,220
-1% -$119K 3.32% 2
2015
Q3 		$12.2M Sell
126,331
-6,778
-5% -$713K 3.34% 2
2015
Q2 		$14M Sell
133,109
-3,072
-2% -$314K 3.33% 2
2015
Q1 		$14.1M Sell
136,181
-1,050
-0.8% -$106K 3.23% 2
2014
Q4 		$13.2M Sell
137,231
-1,400
-1% -$123K 3.05% 2
2014
Q3 		$11M Sell
138,631
-6,020
-4% -$475K 2.57% 2
2014
Q2 		$10.9M Sell
144,651
-4,292
-3% -$324K 2.45% 2
2014
Q1 		$11.2M Sell
148,943
-2,544
-2% -$180K 2.66% 2
2013
Q4 		$10.8M Sell
151,487
-1,989
-1% -$128K 2.6% 2
2013
Q3 		$8.71M Sell
153,476
-552
-0.4% -$32.9K 2.28% 2
2013
Q2 		$8.81M Buy
+154,028
New +$8.92M 2.45% 2

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Catawba Capital Management's CVS Position: Q2 2018 in Review

Catawba Capital Management increased its CVS Health (CVS) stake by 0.58% in Q2 2018, buying an estimated $43K and bringing the position to 113,108 shares worth $7.28M. The position accounts for 1.71% of the portfolio, ranked #8.

Catawba Capital Management first reported a position in CVS in Q2 2013 and has held it in 21 quarters since. The position peaked at $14.1M in Q1 2015. 1,572 funds tracked by Wall St. Rank hold CVS as of Q2 2018.

  • Catawba Capital Management held 113,108 shares of CVS Health worth $7.28M as of Q2 2018.
  • Catawba Capital Management bought 652 CVS Health shares in Q2 2018, an estimated $43K.
  • CVS Health made up 1.71% of Catawba Capital Management's portfolio in Q2 2018, its #8 holding.
  • Catawba Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 21 quarters since.
  • Catawba Capital Management's CVS Health position peaked at $14.1M in Q1 2015.
  • 1,572 funds tracked by Wall St. Rank held CVS Health as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.